'They had the right to know.' Genetic risk and perceptions of responsibility

Psychology and Health

Volumn 23, Issue 6, 2008, Pages 707-727

  Etchegary, Holly ^a   Fowler, Ken ^b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

Genetic decision making; Genetic responsibility; Genetic testing; Huntington disease; Moral obligation

Indexed keywords

ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; CANADA; ETHICS; FAMILY; FEMALE; GENETIC DECISION-MAKING; GENETIC PREDISPOSITION; GENETIC RESPONSIBILITY; GENETIC SCREENING; GENETICS; HUMAN; HUNTINGTON CHOREA; MALE; MIDDLE AGED; MORAL OBLIGATION; QUALITATIVE RESEARCH; SOCIAL BEHAVIOR; UTILIZATION REVIEW; YOUNG ADULT;

GENETIC DECISION-MAKING; GENETIC RESPONSIBILITY; GENETIC TESTING; HUNTINGTON DISEASE; MORAL OBLIGATION;

ADULT; AGED; ATTITUDE TO HEALTH; CANADA; FAMILY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; HUNTINGTON DISEASE; MALE; MIDDLE AGED; QUALITATIVE RESEARCH; SOCIAL RESPONSIBILITY; YOUNG ADULT;

EID: 47249119193     PISSN: 08870446     EISSN: 14768321     Source Type: Journal    
DOI: 10.1080/14768320701235249     Document Type: Article

References (48)

1. Beck, U. (1992). Risk society. London: Sage.
2. Beeson, D. (1997). Nuance, complexity, and context: Qualitative methods in genetic counseling research. Journal of Genetic Counseling, 6, 21-43.
3. Bell, J. (1998). The new genetics in clinical practice. British Medical Journal, 316, 618-620.
4. Brocki, J., & Wearden, A. (2006). A critical evaluation of the use of Interpretative Phenomenological Analysis (IPA) in health psychology. Psychology & Health, 21, 87-108.
5. Chapman, E. (2002). Ethical dilemmas in testing for late onset conditions: Reactions to testing and perceived impact on other family members. Journal of Genetic Counseling, 11, 351-367.
6. Chapman, E., & Smith, J. (2002). Interpretative phenomenological analysis and the new genetics. Journal of Health Psychology, 7, 125-130.
7. Clark, S., Bluman, L., Borstelmann, N., Regan, K., Winer, E., Rimer, B., et al. (2000). Patient motivation, satisfaction and coping in genetic counseling and testing for BRCA1 and BRCA2. Journal of Genetic Counseling, 9, 219-235.
8. Clarke, A., Richards, M., Kerzin-Storrar, L., Halliday, J., Young, M., Simpson, S., et al. (2005). Genetic professionals' reports of nondisclosure of genetic risk information within families. European Journal of Human Genetics, 13, 556-562.
9. Codori, A., & Brandt, J. (1994). Psychological costs and benefits of predictive testing for Huntington's disease. American Journal of Medical Genetics, 54, 174-184.
10. Cox, S. (1999). "It's not a secret but..." Predictive testing and patterns of communication about genetic information in families at risk for Huntington disease. Unpublished doctoral dissertation, The University of British Columbia.
11. Cox, S. (2003). Stories in decisions: How at-risk individuals decide to request predictive testing for Huntington disease. Qualitative Sociology, 26, 257-280.
12. d'Agincourt-Canning, L. (2001). Experiences of genetic risk: Disclosure and the gendering of responsibility. Bioethics, 15, 231-247.
13. d'Agincourt-Canning, L. (2006). Genetic testing for hereditary breast and ovarian cancer: Responsibility and choice. Qualitative Health Research, 16, 97-118.
14. Dawson, S., Kristjanson, L., Toye, C., & Flett, P. (2004). Living with Huntington's disease: Need for supportive care. Nursing and Health Sciences, 6, 123-130.
15. Decruyenaere, M., Evers-Kiebooms, G., Cloostermans, T., Boogaerts, A., Demyttenaere, K., et al. (2004). Predictive testing for Huntington's disease: Relationship with partners after testing. Clinical Genetics, 65, 24-31.
16. Downing, C. (2005). Negotiating responsibility: Case studies of reproductive decision-making and prenatal genetic testing in families facing Huntington disease. Journal of Genetic Counseling, 14, 219-234.
17. Etchegary, H. (2006). Genetic testing for Huntington disease - How is the decision taken? Genetic Testing, 10, 60-67.
18. Forrest Kennan, K., Simpson, S., Wilson, B., van Teijlingen, E., McKee, L., Haites, N., et al. (2005). 'It's their blood not mine:' Who's responsible for (not) telling relatives about genetic risk? Health, Risk & Society, 7, 209-226.
19. Foster, C., Watson, M., Moyhnihan, C., Ardern-Jones, A., & Eeles, R. (2002). Genetic testing for breast and ovarian cancer predisposition: Cancer burden and responsibility. Journal of Health Psychology, 7, 469-484.
20. Galvin, R. (2002). Disturbing notions of chronic illness and individual responsibility: Towards a genealogy of morals. Health, 6, 10-137.
21. Hallowell, N. (1999). Doing the right thing: Genetic risk and responsibility. Sociology of Health & Illness, 21,597-621.
22. Hallowell, N., Jacobs, I., Richards, M., Mackay, J., & Gore, M. (2001). Surveillance or surgery? A description of the factors that influence high risk premenopausal women's decisions about prophylactic oophorectomy. Journal of Medical Genetics, 38, 683-691.
23. Hallowell, N., Foster, C., Eeles, R., Ardern-Jones, A., & Watson, M. (2004). Accommodating risk: Responses to BRCA1/2 genetic testing of women who have had cancer. Social Science & Medicine, 59, 553-565.
24. Hallowell, N., Foster, C., Eeles, R., Ardern-Jones, A., Murday, V., & Watson, M. (2003). Balancing autonomy and responsibility: The ethics of generating and disclosing genetic information. Journal of Medical Ethics, 29, 74-83.
25. Hallowell, N., Ardern-Jones, A., Eeles, R., Foster, C., Lucassen, A., Moynihan, C., et al. (2005). Men's decision-making about predictive BRCA1/2 testing: The role of family. Journal of Genetic Counseling, 14, 207-217.
26. Harper, P. (1996). Huntington's disease. London: Sunders Publishing.
27. Kenea, R. (1994). The human genome project: Creator of the potentially sick, potentially vulnerable and potentially stigmatized? In I. Robinson (Ed), Life and death under high technology medicine (pp. 49-64). London: Manchester University Press.
28. Marteau, T., & Richards, M. P. M. (Eds). (1996). The troubled helix: Social and psychological implications of the new human genetics. Cambridge: Cambridge University Press.
29. Mays, N., & Pope, C. (2000). Assessing quality in qualitative research. British Medical Journal, 320, 50-52.
30. Novas, C., & Rose, N. (2000). Genetic risk and the birth of the somatic individual. Economy & Society, 29, 485-513.
31. Nuffield Council on Bioethics. (1993). Genetic screening: Ethical issues. Available at http://www.nuffieldbioethics.org
32. Petersen, A., & Bunton, R. (2002). The new genetics and the public's health. London: Routledge.
33. Quaid, K., & Wesson, M. (1995). Exploration of the effects of predictive testing for Huntington disease on intimate relationships. American Journal of Medical Genetics, 57, 46-51.
34. Ramsey, S., Wilson, S., Spencer, A., Geidzinska, A., & Newcomb, P. (2003). Attitudes towards genetic screening for predisposition to colon cancer among cancer patients, their relatives and members of the community. Community Genetics, 6, 29-36.
35. Rebbeck, T., Levin, A., Eisen, A., Snyder, C., Watson, P., Cannon-Albright, L., et al. (1999). Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. Journal of National Cancer Institute, 91, 1457-1479.
36. Richards, M. (1998). Annotation: Genetic research, family life and clinical practice. Journal of Child Psychology Q? Psychiatry, 39, 291-305.
37. Richards, F. (2004). Couples' experiences of predictive testing and living with the risk or reality of Huntington disease: A qualitative study. American Journal of Medical Genetics, 126A, 170-182.
38. Richards, F., & Williams, K. (2004). Impact on couple relationships of predictive testing for Huntington disease: A longitudinal study. American Journal of Medical Genetics, 126A, 161-169.
39. Silverman, D. (2000). Doing qualitative research: A practical handbook. London: Sage.
40. Skirton, H., & Glendinning, N. (1997). Using research to develop care for patients with Huntington's disease. British Journal of Nursing, 6, 83-90.
41. Smith, J. A., Flowers, P., & Osborn, M. (1997). Interpretative phenomenological analysis and the psychology of health and illness. In L. Yardley (Ed), Material discourses of health and illness (pp. 68-91). London: Routledge.
42. Smith, J. A., Jarman, M., & Osborn, M. (1999). Doing interpretative phenomenological analysis. In M. Murray & K. Chamberlain (Eds), Qualitative health psychology: Theories and methods (pp. 218-240). London: Sage.
43. Sobel, S., & Cowan, D. (2000). Impact of genetic testing for Huntington disease on the family system. American Journal of Medical Genetics, 90, 49-59.
44. SuttonBrown, M., & Suchowersky, O. (2003). Clinical and research advances in Huntington's disease. Canadian Journal Neurological Science, 30, S45-S52.
45. Taylor, S. (2004). Predictive genetic test decisions for Huntington's disease: Context, appraisal and new moral imperatives. Social Science & Medicine, 58, 137-149.
46. Tibben, A., Timman, R., Bannink, E. C., & Duivenvoorden, H. J. (1997). Three year follow-up after presymptomatic testing for Huntington's disease in tested individuals and partners. Health Psychology, 16, 20-35.
47. Tibben, A., Frets, P., van de Kamp, J., Niermeijer, M., Vegter-van der Vlis, M., Roos, R., et al. (1993). Presymptomatic DNA-testing for Huntington disease: Pretest attitudes and expectations of applicants and their partners in the Dutch program. American Journal of Medical Genetics, 48, 10-16.
48. Warner, B., Curnow, L., Polglase, A., & Debinski, H. (2006). Factors influencing uptake of genetic testing for colorectal cancer risk in an Australian Jewish population. Journal of Genetic Counseling, 14, 387-394.